Prevention of puerperal lactation by a single oral administration of the new prolactin-inhibiting drug, cabergoline.

Melis, G B

Prevention of puerperal lactation by a single oral administration of the new prolactin-inhibiting drug, cabergoline. [electronic resource] - Obstetrics and gynecology Mar 1988 - 311-4 p. digital

Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

0029-7844


Administration, Oral
Adult
Cabergoline
Clinical Trials as Topic
Ergolines--therapeutic use
Female
Humans
Lactation--drug effects
Postpartum Period
Pregnancy
Prolactin--antagonists & inhibitors
Random Allocation